Apontis Pharma AG (ETR:APPH)

Apontis Pharma AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	90	84	40	70	170	-
Market Cap Growth	111.58%	111.58%	-43.23%	-59.00%	-	-
Enterprise Value	75	68	13	37	139	-
Last Close Price	10.85	10.05	4.75	8.20	20.00	-
PE Ratio	119.94	111.09	-	25.92	-	-
Forward PE	33.91	38.29	-	52.63	38.28	-
PS Ratio	1.86	1.73	1.07	1.25	3.32	-
PB Ratio	2.91	2.70	1.31	1.68	4.18	-
P/TBV Ratio	4.77	4.41	1.49	1.93	4.62	-
P/FCF Ratio	-	-	-	6.37	49.59	-
P/OCF Ratio	-	-	-	6.33	49.51	-
PEG Ratio	-	1.56	-	-	-	-
EV/Sales Ratio	1.55	1.39	0.36	0.67	2.73	-
EV/EBITDA Ratio	21.82	19.67	-	6.79	23.95	-
EV/EBIT Ratio	62.71	56.55	-	9.93	32.45	-
EV/FCF Ratio	-25.70	-	-	3.43	40.69	-
Debt / Equity Ratio	-	-	0.20	-	-	4.05
Debt / EBITDA Ratio	-	-	-	-	-	17.29
Debt / FCF Ratio	-	-	-	-	-	9.66
Asset Turnover	0.95	0.95	0.63	0.98	1.22	1.30
Inventory Turnover	3.16	3.16	2.82	5.34	4.63	4.00
Quick Ratio	1.70	1.70	1.20	2.74	3.27	1.03
Current Ratio	2.49	2.49	1.51	3.00	3.79	1.43
Return on Equity (ROE)	2.46%	2.46%	-31.47%	6.54%	-3.37%	-29.21%
Return on Assets (ROA)	1.47%	1.47%	-10.28%	4.14%	6.41%	-1.49%
Return on Capital (ROIC)	2.22%	2.22%	-15.48%	5.73%	9.24%	-2.54%
Return on Capital Employed (ROCE)	3.40%	3.40%	-	8.30%	9.70%	-
Earnings Yield	0.83%	0.90%	-28.57%	3.86%	-0.44%	-
FCF Yield	-3.23%	-3.48%	-31.85%	15.69%	2.02%	-
Buyback Yield / Dilution	-	-	-	2.00%	-30.77%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.